bill soller
SelfCare Co-editor in Chief
Clinical Professor of Pharmacy, University of California, San Francisco
Dr. Bill Soller PhD, is the Executive Director of the Center for Consumer Self Care and Health Sciences Clinical Professor of Pharmacy in the School of Pharmacy, University of California, San Francisco. Between 1985 and 2003, Dr. Soller was Senior Vice President of Science & Technology for the Consumer Healthcare Products Association, the consumer pharmaceutical industry representative body in the US.
Dr. Soller has a broad-based experience in drug and food law, regulations and health policy, and in consumer and pharmaceutical care research. He is principal author of numerous drug and dietary supplement related submissions to the Food Drug Administration (FDA).
Dr. Soller's research interests include a focus on how consumers, as patients, access and use health information and pharmacy care services as a basis to effectively self-manage acute and chronic diseases as well as promote better health through lifestyle changes.
peter noyce cbe
SelfCare Co-editor in Chief
Professor of Pharmacy Practice, University of Manchester
Peter Noyce CBE PhD FRPharmS, is Professor of Pharmacy Practice at the University of Manchester. He has a wide range of publications, including those in Annals of Pharmacotherapy, British Medical Journal, Health Policy, Quality and Safety in Healthcare and Social Science and Medicine, that reflect his major research interests in quality and safety in medicines use, community pharmacy, and regulation. Relevant to his appointment as Co-editor of SelfCare is Professor Noyce’s original contribution to the development and evaluation of pharmacy-based NHS Minor Ailment Schemes in UK.
Professor Noyce was formerly Deputy Chief Pharmacist at the Government Department of Health, London and a UK Medicines Commissioner from 2002-2005. More recently he was appointed by Ministers to be the Professional Advisor to the establishment of the new GB pharmacy regulator, the General Pharmaceutical Council. In 2008 he was made a CBE for services to healthcare.
STEPHEN MANN
SelfCare Managing Editor
Pharmaceutical Consultant
Dr Mann MBBS, MFPM, an experienced pharmaceutical physician, has spent the last 16 years directing the switch to self-medication of several important groups of medicines in Europe, including simvastatin in the UK – a global first. He was Vice President of European R&D at Mc Neil from 1997 – 2005. Since 2005, Dr. Mann has been an independent consultant to the consumer pharmaceutical industry, working with all of the major companies active in Europe.
JOHN D. IRVIN
SelfCare Commissioning Editor for USA Contributors
Consultant to the Pharmaceutical Industry
John D. Irvin, MD, PhD, is a senior pharmaceutical executive with 32 years of experience in the industry. As a vice president of Merck Research Laboratories and senior vice president of Johnson & Johnson•Merck he was responsible for global Rx-to-OTC switch development, the Merck Manual, Merck Index, Clinical Information Services, and Education & Training.
Dr. Irvin is a member of: Academy of Pharmaceutical Physicians and Investigators where he was a founding member and served as trustee, chairman and president; American Society for Clinical Pharmacology and Therapeutics; Drug Information Association; American Heart Association; and the American Society of Hypertension where he served as chairman of the Corporate Affairs Committee.
JUNE M. RAINE, CBE
Director, Post-licensing Division, Medicines and Healthcare Regulatory Agency, UK
Dr June Raine CBE, MSc, MRCP, trained in general medicine in Oxford after completing a Masters degree by research in Pharmacology. Her career in medicines regulation has spanned a number of roles in assessment, management and strategic development within the UK national authority. She was elected in 2005 to chair the CHMP’s Pharmacovigilance Working Party, and is also a member of the WHO Advisory Committee on Safety of Medicinal Products. Her special interests are in monitoring the outcomes of regulatory action, risk communication and patient involvement in the regulatory process.
Dr. Raine is recognized as a thought leader in the area of legal classification of medicines. In 2009 she was appointed CBE in recognition of her work in medicines regulation.
DAVID B. NASH
Professor Of Health Policy and Founding Dean of the Jefferson School of Population Health,
Thomas Jefferson University in Philadelphia
Dr. Nash M.D., MBA, FACP is internationally recognized for his work in outcomes management, medical staff development and quality-of-care improvement; his publications have appeared in more than 100 articles in major journals and he has edited nineteen books.
He is on the board of directors and advisory board of multiple healthcare companies. Currently, he is Editor-in-Chief of four major national journals including P&T, Population Health Management, Biotechnology Healthcare and the American Journal of Medical Quality.
RANDY P JUHL
University of Pittsburgh Vice Chancellor for Research Conduct and Compliance, and Distinguished Service Professor of Pharmacy in the School of Pharmacy
Dr. Juhl served as President of the Academy of Pharmaceutical Research and Science in the American Pharmaceutical Association in 1992 to 1993, and as chair of the newly created FDA advisory committee on non-prescription drugs from 1992 t
Currently Dr. Juhl consults for several companies and organizations that deal with self-medication and the Rx to OTC switch process and is a frequent speaker on a variety of FDA-related regulatory topics.
ALISON BLENKINSOPP
Professor of the Practice of Pharmacy at Keele University
Alison is Professor of Pharmacy Practice at Keele University in the UK, where she works in the multi-disciplinary Medicines Management group. She has researched and written extensively on self care, with a particular interest in over the counter (non-prescription) medicines. She is lead author of the bestselling textbook “Symptoms in the Pharmacy”, now in its 6th edition, as well as the British Medical Association’s expert rep
Associate Editors
Julie Aker,
President and CEO of Concentrics Research, a clinical research organisation.
Professor Ian Banks,
Professor of General Practice and President of the European Men's Health Forum.
Professor Christine Bond,
Head of Centre of Academic Primary Care, University of Aberdeen.
Dr. David Bradford,
Senior Vice President for OTC Switches, PEGUS Research, Inc.
Dr. Philip Chan,
Telepharmacy and Special Programs Manager; WOS Health Sciences Asst. Professor. University of California, San Francisco.
Jerry Cottrell,
Director of Clinical Affairs, Johnson&Johnson Ltd.
Dr. Hubertus Cranz,
Director General, AESGP (European Self Medication Industry Body)
Dr. John Dent,
Former GSK executive with responsibility for Rx to OTC switch.
Dr. Janet Engle
Professor and Head, Dept. of Pharmacy Practice, University of Illinois.
Dr. Edwin Hemwall,
Merck OTC drug development, Head of Regulatory Affairs.
Dr. Robert Hofmann,
Director, Medical Affairs, Johnson & Johnson
Peter Barton Hutt,
Former chief counsel at Food and Drug Administration (FDA).
Dr. Edward B. Nelson,
Medical Director, Martek Biosciences.
Ruth Parker,
Professor of Medicine at Emory University School of Medicine.
Jim Phillips
Director, Quality institute for self-management education and training and self-management consultant.
Professor Mike Pringle,
Professor of General Practice, past president of Royal College of General Practitioners.
Dr. Paul Rutter,
Principal Lecturer, University of Wolverhampton.
Dr. Saul Shiffman
Professor of Psychology, University of Pittsburgh, Senior Scientific Advisor to Pinney Associates.
Dr. Michela Tinelli
Visiting Research Fellow, London School of Economics, Health.
Return to Top
CPPE Pharmacist Case Book Quiz
